These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32249473)

  • 1. Closure of the left atrial appendage using percutaneous transcatheter occlusion devices.
    Gianni C; Anannab A; Sahore Salwan A; Della Rocca DG; Natale A; Horton RP
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2179-2186. PubMed ID: 32249473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
    Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
    Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous closure of a very large left atrial appendage using the Amplatzer amulet.
    Freixa X; Kwai Chan JL; Tzikas A; Garceau P; Basmadjian A; Ibrahim R
    Can J Cardiol; 2013 Oct; 29(10):1329.e9-1329.e11. PubMed ID: 23541662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Occlusion Device Implantation: the Role of the Echocardiographer.
    Altszuler D; Vainrib AF; Bamira DG; Benenstein RJ; Aizer A; Chinitz LA; Saric M
    Curr Cardiol Rep; 2019 Jun; 21(7):66. PubMed ID: 31183616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter cerebral embolic protection during WATCHMAN procedure in two patients with persistent left atrial appendage thrombus: Case report with review of the literature.
    Tan BE; Depta JP
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):365-368. PubMed ID: 32538522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation.
    Regueiro A; Cruz-Gonzalez I; Bethencourt A; Nombela-Franco L; Champagne J; Asmarats L; Jiménez-Quevedo P; Rodriguez-Gabella T; Rama-Merchan JC; Puri R; O'Hara G; Rodés-Cabau J
    J Interv Card Electrophysiol; 2018 Jun; 52(1):53-59. PubMed ID: 29564664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?].
    Boersma LVA; Rensing BJWM; Wintgens LI; Klaver M; Swaans MJ
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetech LAmbre: a new promising and novel device in the interventional stroke prevention.
    Schnupp S; Ajmi I; Brachmann J; Mahnkopf C
    Future Cardiol; 2019 Nov; 15(6):405-410. PubMed ID: 31710249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke.
    Mosley WJ; Smith MR; Price MJ
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):664-9. PubMed ID: 24214652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure.
    Della Rocca DG; Horton RP; Di Biase L; Bassiouny M; Al-Ahmad A; Mohanty S; Gasperetti A; Natale VN; Trivedi C; Gianni C; Burkhardt JD; Gallinghouse GJ; Hranitzky P; Sanchez JE; Natale A
    JACC Cardiovasc Interv; 2020 Feb; 13(3):306-319. PubMed ID: 31954677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caged-in: Successful percutaneous closure of left atrial appendage with Watchman-FLX in the presence of proximal thrombus.
    Briosa E Gala A; Pope MTB; Newton JD; Dawkins S; Betts TR
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1655-1657. PubMed ID: 33938078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke.
    Viles-Gonzalez JF; Reddy VY; Petru J; Mraz T; Grossova Z; Kralovec S; Neuzil P
    J Interv Card Electrophysiol; 2012 Jan; 33(1):69-75. PubMed ID: 21947786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.